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Abstract 
The role of cyclic AMP as a second messenger in the stimulation of protein synthesis and the potential involvement of mitogen 
activated protein (MAP) kinase in this response was studied in L6 myoblasts. Dibutyryl-cAMP (dbt-cAMP) increased protein synthesis at 
90 min and 6 h in a concentration-dependent ma ner. The responses at 90 min were probably mediated by increased translation as they 
were not blocked by actinomycin D; effects at 6 h were accompanied by increases in RNA content implying a transcriptional component. 
100 nM 12-0-tetradecanoylphorbol-13-acetate (TPA), 1 nM Insulin (90 min incubations) and 100 nM vasopressin (6 h incubation) also 
increased protein synthesis and these responses were additive with those of 500 /xM dbt-cAMP. Responses to forskolin were similar to 
dbt-cAMP whilst 1,9-dideoxyforskolin had no effect. Cell extracts immunoblotted with MAP kinase antibody showed bands correspond- 
ing to approx. 42, 44, 54 and 83 kDa. 500 /xM dbt-cAMP elicited an increase in activity of both the 42 and 44 kDa bands when assayed 
by the 'in gel' method and a similar response was also observed with forskolin. TPA and vasopressin also stimulated the activity of these 
two isoforms, but had no significant additive or inhibitory effects when added in combination with 500 /zM dbt-cAMP. In contrast, 
although I nM insulin alone had no effect, a synergistic response in terms of MAP kinase activation was observed in the presence of 
dbt-cAMP. The data demonstrate hat cAMP stimulates protein synthesis in L6 cells and suggest a role for MAP kinase in this event. 
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1. Introduct ion 
Extracellular stimuli control events such as protein syn- 
thesis by binding to specific membrane receptors on their 
Abbreviations: PLA 2, phc,spholipase A2; PLC, phospholipase C; 
PLD, phospholipase D; cAMP, adenosine 3',5'-cyclic monophosphate; 
dbt-cAMP, N6,2'-0-dibutyryladenosine 3':5'-cyclic monophosphate; TPA, 
12-0-tetradecanoylphorbol-13-acetate; PKC, protein kinase C; DMEM, 
Dulbecco's modified Eagle's medium; MBP, myelin basic protein; EDL, 
extensor digitorum longus; Pgak, protein kinase A; MAP kinase, mitogen 
activated protein kinase; PMSF, phenylmethylsulphonylfluoride; DTI', 
dithiothreitol; SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis; p70 s6k, 70 kDa $6 kinase; p90 rsk, 90 kDa $6 kinase; 
CRE, cAMP-responsive len~mt; CREB/ATF, cAMP-responsive le- 
ment binding proteins family; CREM, cAMP-responsive lement modula- 
tor. 
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target cells leading to second messenger production and 
the activation of signalling cascades. In recent years, con- 
siderable attention has focused on the involvement of 
pathways initiated by the activation of phospholipases, 
particularly A :  (PLA2), C (PLC) and D (PLD) [1-5]. 
We are interested in the mechanisms regulating protein 
synthesis in skeletal muscle. Using L6 skeletal muscle 
myoblasts as a model, there is evidence of roles for 
arachidonate conversion to cyclooxygenase metabolites 
[6,7] and the activation of both protein kinase C (PKC) [8] 
and PLD [9] in the stimulation of this event. 
However, one pathway which has received considerably 
less attention is the possible involvement of cyclic AMP 
(cAMP) and the cAMP-dependent protein kinase (protein 
kinase A, PKA) in this process. Thus, the first objective of 
this work was to investigate the response of L6 cells, with 
regard to both translation and transcription, to increased 
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concentrations of cAMP. Secondly, we wished to examine 
the ability of cAMP to influence the stimulation of protein 
synthesiS induced by insulin [6], 12-0-tetradecanoylphor- 
bol-13-acetate (TPA) and vasopressin [9]. 
The pathways leading from cAMP and PKA to changes 
in protein synthesis are incompletely understood. Phospho- 
rylation of 40S ribosomal protein $6 is elicited by agents 
(including cAMP and PKA [10,11]) in a wide variety of 
cells and this correlates with increased rates of translation 
[12-16]. Although PKA can directly phosphorylate $6, 
there are also two distinct $6 kinase families; the 70 kDa 
(p70 s6k) and 90 kDa (p90 rsk) [17,18]. The signalling 
cascade regulating p70 s6k is poorly understood but it can 
be inhibited by rapamycin [19] and stimulated by elevation 
of cAMP [20]. In contrast, p90 rsk is phosphorylated and 
activated by mitogen activated protein (MAP) kinase 
[21,22]. Furthermore, upon stimulation, MAP kinase has 
been shown to translocate from the cytoplasm to the 
nucleus and influence transcriptional events through the 
regulation of factors such as c-Myc, c-Jun, c-Fos and 
ATF-2 [23]. In both COS-7 [24] and PC12 [25] cells, 
cAMP has been shown to activate MAP kinase. Thus, we 
have also investigated the possibility that cAMP, either 
alone or in combination with other agonists, might alter 
translation and/or transcription rates, at least in part, via a 
mechanism which involves MAP kinase. 
2. Materials and methods 
2.1. Materials 
2.2. Culture of L6 cells 
L6 cells (European Collection of Animal Cell Cultures, 
Porton Down, Salisbury, Wilts., UK) were grown on 60- 
mm Petri dishes (Greiner, Dursley, Glos.) in 2.5 ml of 
Dulbecco's modified Eagle's medium (DMEM) containing 
12% foetal calf serum as described previously [6] and used 
before the onset of fusion when they were approx. 75% 
confluent and each dish contained 1mg total protein. 2 ml 
of serum-free DMEM was then added to each dish for 18 h 
and the cells were used as described below. 
2.3. Preparation and immunoblotting of cell extracts 
Myoblasts were incubated with various agents at con- 
centrations and for times as specified in the figure legends. 
The dishes were then rinsed three times with ice-cold 
phosphate-buffered saline and extracts were prepared as 
described previously [30]. 40 /zl of cell extracts were 
added to 20 /.tl sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) sample buffer (5% (w/v) 
SDS, 13% (w/v) glycerol, 60 mM Tris-HC1, 0.2% bro- 
mophenol blue and 5% mercaptoethanol, pH 6.8) and 
heated at 100°C for 5 min. Samples were then separated by 
10% SDS-PAGE and immunoblotted with antibody to 
MAP kinase as described [31]. The pan MAP kinase and 
secondary antibody were used at dilutions of 1:250 and 
1:5000 respectively. The blocking solution comprised 50 
mM Tris-HC1 and 150 mM NaCI containing 1% Tween 
20. All antibody incubations were performed in the same 
buffer containing 0.5% Tween 20. 
/3-glycerophosphate, sodium orthovanadate, phenyl- 
methylsulphonylfluoride (PMSF), leupeptin, dithiothreitol 
(DTT), myelin basic protein (MBP), sodium pyrophos- 
phate, N 6, 2'-0-dibutyryladenosine 3',5'-cyclic monophos- 
phate (dbt-cAMP), forskolin, 1,9-dideoxyforskolin, actino- 
mycin D, TPA and vasopressin were from Sigma (Poole, 
Dorset, UK). L-[2,63H]Phenylalanine, [7-32p]ATP and 
ECL Western blotting reagents were obtained from Amer- 
sham International (Amersham, Bucks., UK) and all tissue 
culture media were purchased from Life Technologies 
(Paisley, Scotland). ATP was obtained from Boehringer 
(Lewes, East Sussex, UK) and 3 MM paper was from 
Whatman (Maidstone, Kent, UK). A widely used (e.g., 
Refs. [26,27]) pan monoclonal ntibody which recognises a 
strongly conserved MAP kinase core peptide sequence 
(residues 219-358 of rat p42) and cross-reacts extensively 
with proteins of 42, 44, 54 and 85 kDa and a polyclonal 
anti-mouse horseradish peroxidase conjugate were pur- 
chased from Affiniti Research Products, Nottingham, UK. 
The peptide corresponding to the N-terminal third of the 
heat stable PKA inhibitor [28,29] was from Bachem (Saf- 
fron Walden, Essex, UK) and rapamycin was obtained 
from Calbiochem (Beeston, Notts., UK). 
2.4. Assay of MBP kinase activity 
Total MBP kinase activity was assayed with 25 /zl of 
cell extract (approx. 0.15-0.2 mg/ml protein) using What- 
man phosphocellulose paper [30]. In order to determine the 
activity status of MAP kinase isoforms detected by im- 
munoblotting, parallel aliquots of cytosolic extracts were 
resolved by SDS-PAGE in MBP-containing els. Briefly, 
cell extracts were subjected to 10% SDS-PAGE in gels 
containing 0.25 mg/ml MBP. SDS was removed by two 
30 min washes at room temperature with 100 ml 50 mM 
Tris, 5 mM mercaptoethanol (Buffer A, pH 8) containing 
20% 2-propanol. Following a further 45-min wash with 
buffer A, proteins were completely denatured by two 
30-min washes at room temperature with 100 ml buffer A 
containing 6 M guanidine-HC1. Subsequently, proteins were 
renatured for 18 h at 4°C in buffer A containing 0.04% 
Tween 40. Following this stage, the gel was preincubated 
at room temperature (22°C) for 30 min in 50 ml 40 mM 
Hepes containing 2 mM DTT, 0.1 mM EGTA and 5 mM 
MgCI 2 (Buffer B, pH 8). Phosphorylation was then initi- 
ated by layering 4 ml buffer B containing 25 /xM ATP 
with 25/zCi [-y-32p]ATP onto the gel. After 1 h incubation 
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at room temperature, the reaction was terminated by re- 
moving the buffer and immersing the gel in 500 ml 5% 
TCA containing 1% sodium pyrophosphate. It was then 
washed 4 × 1 h in this solution, dried, subjected to auto- 
radiography and the band intensities were determined by 
densitometry on a Howtek Scanmaster with a Mill±pore 
bio-image software package. The apparent molecular 
weights of proteins resolved by this method were deter- 
mined by reference to pre-stained molecular weight mark- 
ers. 
Table 1 
Concentration-dependent effects of dibutyryl-cAMP on protein synthesis 
at 90 min and 6 h in L6 myoblasts 
Dibutyryl-cAMP Specific radioactivity d.p.m.//xg protein 
(p,M) (90 rain) (6 h) 
0 10.0±0.1 9.8±0.2 
1 10.1±0.2 9.9±0.3 
10 9.9±0.2 9.6±0.2 
1~ 10.7±0.1 a 10.1±0.2 
5~ 11.6±0.2 a 11.8±0.3 a
1000 11.7±0.1 a 12.5±0.2 a
2.5. Measurement of protein synthesis and RNA accretion 
Following identical pre-treatment of cells for 18 h, the 
effects of dbt-cAMP (0-1 mM), forskolin (0-100 /zM) 
and 1,9-dideoxyforskolin (25 /xM) on protein synthesis in 
the presence and absence of actinomycin D (1 /xg/ml) 
were measured. In a further series of experiments, cells 
were treated with either dbt-cAMP or forskolin for 10 min 
prior to the addition of insulin (Actrapid, monocomponent 
porcine diluted in serum-free medium), TPA or vaso- 
pressin. Incubations were for either 90 rain or 6 h as 
specified in the table legends and protein synthesis was 
measured over the final 60 rain of the incubation by 
adding 10 /z l /ml of medium of a 75 mM aqueous tock 
solution of phenylalanine which contained 50 /~Ci of 
L-[2,63H]phenylalanine/ml. Subsequent treatment to de- 
termine the specific radioactivity of protein-bound phenyl- 
alanine and total RNA content was as described previously 
[32]. 
2.6. Presentation of results and statistics 
All protein synthesis experiments were done with n = 5 
and are expressed as d.p.m.//~g protein. Measurements of
total MBP kinase activity were performed with n = 3 and 
are expressed as c.p.m./k,.g protein. All experiments were 
performed at least twice under identical conditions and 
most observations were w~rified on 3-4 occasions. Analy- 
sis of variance was performed where necessary and results 
are shown as means_  S.E.M. with significance being 
assessed by Student's t-test. Immunoblots and 'in gel' 
assays are presented as individual experiments which were 
performed at least three times with independent cell ex- 
tracts and gave qualitatively identical results. 
3. Results 
The addition of dbt-c2MMP to L6 myoblasts elicited a 
concentration-dependent increase in protein synthesis at 
both 90 min and 6 h. A significant effect at 90 min was 
first observed with 100 p~M dbt-cAMP, whereas 500 p,M 
was required to elicit an increase at 6 h (Table 1). The 
maximum response observed with 1 mM dbt-cAMP was 
17% at 90 min and 28% at 6 h. Furthermore, dbt-cAMP 
L6 myoblasts were incubated with increasing concentrations of dbt-cAMP 
for either 90 min or 6 h. [3H]Phenylalanine was present for the final 60 
min and protein synthesis was measured as described in Section 2. Data 
are means of 10 (2 combined experiments each with 5 dishes per 
treatment) + S.E.M.; analysis of variance showed no significant differ- 
ence between experiments which have been combined. By Student's 
t-test, a significantly different from control P < 0.001. 
also stimulated RNA accretion over the same concentra- 
tion range at 6 h (e.g., for 500 /xM dbt-cAMP, total RNA 
content increased from 61.4_ 1.7 to 72 ± 1.4 /zg/dish, 
n = 5; P < 0.001). 
Actinomycin D (1 /xg/ml) had no effect on the stimu- 
lation of protein synthesis in response to 500 /zM dbt- 
cAMP at 90 min which increased 17% from 10.1 + 0.3 to 
11.8 + 0.3 dpm/~g protein (n = 5; P < 0.01) in the ab- 
sence of actinomycin D and 19% from 8.6 + 0.1 to 10.2 +__ 
0.1 dpm//xg protein (n = 5, P < 0.001) in its presence. 
A 10-rain preincubation with the 70 kDa $6 kinase 
inhibitor, rapamycin (100 nM), also had no effect on the 
ability of 500/zM dbt-cAMP to stimulate protein synthesis 
during a 90-min incubation. Phenylalanine sequestration 
increased from 10.2 ___ 0.2 to 12.3 +__ 0.2 dpm//zg protein 
in the absence of rapamycin (21% increase, P < 0.001; 
n = 10 from 2 combined experiments) and from 9.5 + 0.2 
to 11.7 + 0.2 dpm//xg protein in its presence (23% in- 
crease, P < 0.001" n = 10 from 2 combined experiments). 
When L6 cells were preincubated for 10 rain with 500 
/zM dbt-cAMP and then challenged with either 1 nM 
insulin or 100 nM TPA for 90 min, the stimulation of 
protein synthesis induced by dbt-cAMP was additive to 
that produced by both insulin and TPA (Table 2). How- 
ever, when similar experiments were performed over a 6 h 
incubation, the responses produced by dbt-cAMP and va- 
sopressin (100 nM) were additive, but insulin did not 
significantly increase the dbt-cAMP effect (Table 3). 
In order to confirm that the responses to dbt-cAMP 
were mediated by cAMP, we used forskolin as an alterna- 
tive way of elevating cAMP. Forskolin increased protein 
synthesis at both 90 min and 6 h (Table 4). Like the 
response to dbt-cAMP, a higher concentration of forskolin 
was required to stimulate protein synthesis at 6 h (10/xM) 
than 90 min (1 ~M). At an optimal concentration of 25 
/xM, forskolin stimulated protein synthesis by 16% at 90 
min and by 24% at 6 h (Table 4). In addition, 25 /~M 
forskolin also increased the RNA content of the cultures at 
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Table 2 
Effects of dibutyryl-cAMP alone and in combination with either insulin 
or TPA on protein synthesis at 90 min in L6 myoblasts 
Specific radioactivity % increase 
d.p.m.//zg protein 
Control 10.1 ± 0.2 - 
Insulin 11.1 ± 0.2 ~ 10 
TPA 11.3-1-0.3 b 12 
Dbt-cAMP 11.8 ± 0.3 a 17 
Dbt-cAMP + insulin 12.6 ± 0.2 ~c,e 25 
Dbt-cAMP + TPA 12.7 ± 0.2 ~,d.e 26 
L6 myoblasts were incubated with either dbt-cAMP (500/zM), insulin (1 
nM), TPA (100 nM) or combinations of dbt-cAMP with either insulin or 
TPA for 90 min. [3H]Phenylalanine was present for the final 60 min and 
when combinations of agonists were used, dbt-cAMP was added 10 rain 
before either insulin or TPA. Data are means of 10 (2 combined experi- 
ments each with 5 dishes per treatment) ±S.E.M.; analysis of variance 
showed that although the magnitude of the responses in the two experi- 
ments were significantly different, the effects of combinations of agonists 
were significantly different from the individual agonists in both experi- 
ments which have therefore been combined. By Student's t-test, a signifi- 
cantly different from control P < 0.001; b significantly different from 
control P < 0.01; ~ significantly different from insulin alone P < 0.01; 
d significantly different from TPA alone P < 0.01; e significantly differ- 
ent from cAMP alone P < 0.05. 
6 h from 60.2 ___ 1.4 to 66.0 _ 0.6 /zg/dish (n = 5; P < 
0.01). In contrast, the inactive forskolin analogue, 1,9-di- 
deoxyforskolin (25 /zM), failed to stimulate protein syn- 
thesis at 90 min (10.1 + 0.2 vs 9.9 + 0.2 dpm//zg protein, 
n = 5) and 6 h (data not shown) or RNA accretion at 6 h 
(60.2 _ 1.4 vs 59.7 + 0.6 /zg/dish, n = 5). Furthermore, 
Table 3 
Effects of dibutyryl-cAMP alone and in combination with either insulin 
or vasopressin on protein synthesis at 6 h in L6 myoblasts. 
Specific radioactivity % increase 
d.p.m.//xg protein 
Control 10.0 ± 0.2 - 
Insulin 11.7 ± 0.3 a 17 
Vasopressin 11.8 + 0.2 a 18 
Dbt-cAMP 12.4 ± 0.3 ~ 24 
Dbt-cAMP + insulin 12.9 ± 0.5 abe 29 
Dbt-cAMP + vasopressin 14.0 ± 0.5 ~de 40 
L6 myoblasts were incubated with either dbt-cAMP (500/aM), insulin (1 
nM), vasopressin (100 nM) or combinations of dbt-cAMP with either 
insulin or vasopressin for 6 h. [3H]Phenylalanine was present for the final 
60 rain and when combinations of agonists were used, dbt-cAMP was 
added 10 min before either insulin or vasopressin. Data are means of 10 
(2 combined experiments each with 5 dishes per treatment) ±S.E.M.; 
analysis of variance showed that although the magnitude of responses in
the two experiments were significantly different, the effect of dbt-cAMP 
+ vasopressin was significantly different from either agonist alone in 
both experiments. In contrast, he response to dbt-cAMP + insulin was not 
significantly different from dbt-cAMP in either experiment; the data has 
therefore been combined. By Student's t-test, a significantly different 
from control P < 0.001; b significantly different from insulin alone P < 
0.05; c not significantly different from cAMP alone; ~ significantly differ- 
ent from vasopressin alone P <0.001; e significantly different from 
cAMP alone P < 0.01. 
Table 4 
Concentration-dependent effects of forskolin on protein synthesis at 90 
min and 6 h in L6 myoblasts. 
Forskolin Specific radioactivity 
(/zM) d.p.m.//zg protein 
(90 min) (6 h) 
0 9.9+0.2 10.1±0.2 
1 10.6±0.2 c 9.9±0.2 
10 11.7±0.2 a 11.1±0.2 b
25 12.0+0.3 a 12.5±0.1 a
50 11.2±0.3 a 11.4±0.1 ~ 
75 10.5±0.2 11.3±0.2 a
L6 myoblasts were incubated with increasing concentrations of forskolin 
for either 90 min or 6 h. [3H]Phenylalanine was present for the final 60 
min and protein synthesis was measured as described in Section 2. Data 
are means of 10 (2 combined experiments each with 5 dishes per 
treatment) + S.E.M.; analysis of variance showed no significant differ- 
ence between experiments which have been combined. By Student's 
t-test, a significantly different from control P <0.001; b significantly 
different from control P < 0.01; ¢ significantly different from control 
P < 0.05. 
when L6 myoblasts were incubated with forskolin for 10 
min and then treated with either 1 nM insulin or 100 nM 
TPA for 90 min or 1 nM insulin or 100 nM vasopressin for 
6 h, the responses obtained were additive in an identical 
manner to those observed with dbt-cAMP (data not shown). 
SDS-PAGE and immunoblotting of non-stimulated cy- 
tosolic cell extracts with antibody to MAP kinase revealed 
proteins corresponding to approx. 42, 44, 54 and 83 kDa 
(Fig. 1). Although basal levels were high, 500 /xM dbt- 
cAMP and 25 ~M forskolin had no effect on total MBP 
kinase activity during 30-min treatments. For example, 
after a 5-min incubation, dbt-cAMP and forskolin both 
failed to alter MBP kinase activity (1344 _ 49 vs 1443 __+ 73 
cpm//zg protein, n = 6 from 2 combined experiments) 
and (1344 _ 49 vs 1390 _ 40 cpm//zg protein, n = 6) 
respectively. 
However, when extracts were subjected to SDS-PAGE 
in the presence of MBP and renatured, cells treated with 





Fig. 1. Immunobiotting of extracts from L6 myoblasts with pan antibody 
to MAP kinase. Two unstimulated cell extracts prepared from L6 my- 
oblasts were subjected to 10% SDS-PAGE, transferred to nitrocellulose 
and immunoblotted asdescribed in Section 2. Arrows indicate the four 
protein bands of approx. 42, 44, 54 and 83 kDa that were detected. 
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Fig. 2. Stimulation ofMAP kinase activities in L6 myoblasts by dbt-cAMP (500 /xM), forskolin (25 /zM), TPA (100 nM) and vasopressin (100 nM). L6 
myoblasts were treated with either dbt-cAMP for times up to 1 h or TPA, vasopressin (VP) or forskolin (FK) for 5 min. Extracts were prepared and 
separated by 10% SDS-PAGE that contained 0.25 mg/ml MBP. The assay for kinase activity and autoradiography were performed asin Section 2. The 
autoradiograph shown is from a representative experiment ofthree. 
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Fig. 3. Effects of dbt-cAMP (500/zM) in combination with either TPA (100 nM), vasopressin (100 nM) or insulin (1 nM) on MAP kinase activities in L6 
myoblasts. Cells were incubated for 5 min with either vehicle (1), dbt-cAMP (2), TPA (3), vasopressin (4), insulin (5), dbt-cAMP + TPA (6), 
dbt-cAMP + vasopressin (7) or dbt-cAMP + insulin (8). Extracts were prepared and assayed for activity as described in Section 2. The autoradiograph 
shown is from a representative experiment of three. 
phosphorylation of bands corresponding to the 42 /44  kDa 
forms of MAP kinase (Fig. 2). Reproducible increases in 
both isoforms were observed within 5 min; the effect on 
the 42 kDa MAP kinase appeared biphasic, whereas that 
on the 44 kDa isoform was more sustained (Table 5). 
Furthermore, a 5-min incubation with 25 /zM forskolin 
also stimulated both isoibrms of MAP kinase (Fig. 2). 
However, the responses to dbt-cAMP and forskolin were 
small when compared to those elicited by TPA and vaso- 
pressin (Fig. 2, Table 5). 
Table 5 
Effects of dbt-cAMP, forskolin, TPA and vasopressin on MAP kinase 
activity in L6 myoblasts 
Agonist Time Arbitrary absorbance units 
(min) 42 kDa 44 kDa 35-40 kDa 
- 0 0.032 0.102 1.6 
500/xM dbt-cAMP 1 0.042 0.129 1.4 
5 0.051 0.229 2.2 
10 0.106 0.467 2.0 
20 0.026 0.298 2.4 
40 0.050 0.392 1.8 
60 0.095 0.422 1.2 
25/xM Forskolin 5 0.127 0.342 1.4 
100 nM TPA 5 0.409 2.63 2.2 
100 nM VP 5 0.112 1.14 2.4 
L6 myoblasts were incubated with agonist, extracts prepared and sub- 
jected to SDS-PAGE in MBP-containing els. Following renaturation, 
MBP kinase was assayed and data analysed as described in Section 2. 
Data are from a representative experiment of 3 which gave qualitatively 
identical results. 
Additional bands (35-40 kDa) were observed below the 
two MAP kinase isoforms. In some experiments, a single 
band was detected, whereas in others it was resolved into 
two. The phosphorylation state of these bands showed no 
reproducible changes in response to any of the agonists 
used (Figs. 2 and 3, Table 5). The MAP kinase antibody 
failed to detect any proteins in this area of the gel (Fig. 1) 
and the bands were not present when the assay procedure 
was repeated in the absence of MBP (data not shown). No 
activity corresponding to either the 54 or 83 kDa bands 
was observed in any unstimulated or agonist-treated ex- 
tracts (data not shown). 
When agonists were added in combination, dbt-cAMP 
had no reproducible ffects on the stimulation of MAP 
kinase elicited by either TPA or vasopressin (Fig. 3). 
However, a synergistic effect, particularly with regard to 
the 42 kDa isoform was observed when dbt-cAMP was 
added in combination with insulin (Fig. 3). For example, 
dbt-cAMP or insulin alone for 5 min gave absorbance 
values of 0.08 and 0.06 (compared with 0.05 for the 
control), but in combination achieved a value of 1.00. 
Similarly, for the 44 kDa isoform, dbt-cAMP and insulin 
gave values of 0.34 and 0.16 alone (0.13 for the control) 
and 0.68 when added together. 
4. Discuss ion 
We demonstrate in this study, using two agents (dbt- 
cAMP and forskolin) which have the ability to elevate 
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intracellular cAMP, that this second messenger plays a 
positive role in the regulation of protein synthesis in L6 
cells. Dbt-cAMP permeates the plasma membrane and is 
metabolized in the cell to generate cAMP [33]. The data 
clearly demonstrate hat this agent stimulates protein syn- 
thesis at both 90 min and 6 h. The effect at 90 min was 
mediated through an increase in translation as it was not 
inhibited by actinomycin D and there was no change in 
RNA accretion, whereas the enhanced RNA accretion at 6 
h implies a transcriptional component to the response. The 
effect of dbt-cAMP was additive to the effects of insulin 
and TPA at 90 min and vasopressin at 6 h. Interestingly, a 
previous study which measured changes in translation 
using intact extensor digitorum longus (EDL) muscle 
demonstrated that 1 mM dbt-cAMP in the presence of 0.01 
units/ml of insulin (approx. 70 nM), significantly in- 
creased the rate of protein synthesis above that observed 
with insulin alone [34]. Unfortunately, the effect of 1 mM 
dbt-cAMP alone was not recorded, but the data suggest 
that the phenomenon we have observed in the L6 cell also 
occurs in intact skeletal muscle and thus these cells appear 
a satisfactory model with which to investigate these effects 
further. 
Unlike dbt-cAMP, forskolin is a potent activator of 
adenylate cyclase through a direct action at the level of the 
catalytic subunit [35]. A previous study in L6 cells has 
shown that forskolin effectively elevates cAMP levels in a 
concentration-dependent manner whilst having no effect 
On insulin binding [36]. The finding that forskolin (but not 
the inactive forskolin analogue, 1,9-dideoxyforskolin [37]) 
mimics the effects of dbt-cAMP on protein synthesis in L6 
cells strongly supports a role for cAMP in these events. 
Furthermore, the observation that optimal concentrations 
of vasopressin and TPA were additive with those of cAMP 
implies that the effects of these two agents on protein 
synthesis are not mediated through cAMP; instead their 
action may involve inositol lipid hydrolysis by PLC or 
phosphatidylcholine breakdown by PLD [9]. 
It is also unlikely that the effects of insulin are mediated 
by cAMP. We chose to use a physiologically relevant 
concentration of insulin rather than a concentration which 
gives a maximal response as we were interested in the 
physiological relevance of our findings. At the concentra- 
tion chosen (1 nM), the additive effect was only observed 
at 90 min, suggesting that the mechanism of insulin action 
on translation and transcription is different. This observa- 
tion is supported by previous studies suggesting a role for 
PKC in insulin stimulation of transcription and cyclooxy- 
genase metabolites in its stimulation of translation [6-8]. It 
is also interesting to note that a higher concentration of 
both dbt-cAMP and forskolin was required to stimulate 
protein synthesis at 6 h than at 90 min. The explanation for 
this is not clear at present but may again reflect the 
different pathways regulating translation and transcription. 
In mammalian cells, there are some reports of a direct 
action of cAMP independent of PKA [38-41]. However, 
most of the effects ascribed to cAMP do involve PKA but 
whether it is involved in the effects on protein synthesis 
described here is not known. 
Purified PKA has been shown to phosphorylate s veral 
initiation factors and elongation factor-2 kinase [42]. Both 
PKA and elevated levels of intracellular cAMP have been 
shown to stimulate ribosomal protein $6 phosphorylation 
[10,11] which in turn may promote the recruitment of 
mRNA to increase the number of polysomes [12-16]. 
A potential pathway linking cAMP to the phosphoryla- 
tion of $6 (through p90 rsk) involves the MAP kinase 
cascade. Immunoblotting cell extracts with a pan MAP 
kinase antibody revealed, in addition to the classical 42 
and 44 kDa isoforms, two additional bands of 54 and 83 
kDa. The 54 kDa band is most likely the stress-activated 
MAP kinase (e.g., [43]) and although the exact nature of 
the 83 kDa band is unknown, a previous study with this 
antibody has identified a band of similar molecular weight 
in HeLa cells and in mouse macrophages and fibroblasts 
[44]. Our preliminary experiments measuring total MBP 
kinase activity failed to demonstrate any response to either 
dbt-cAMP or forskolin although it was noticeable that 
basal activity was higher than in many other reports. When 
cell extracts were subjected to the 'in gel' assay (Figs. 2 
and 3), it became clear that MBP was also phosphorylated 
by an activity which was not detected by the MAP kinase 
antibody (Fig. 1). The identity of this activity is currently 
unknown; it did not appear to be due to enzyme autophos- 
phorylation as the band(s) was not present in the absence 
of MBP. The 'in gel' assay thus revealed small, but 
reproducible ffects of dbt-cAMP and forskolin on the 42 
and 44 kDa isoforms of MAP kinase. Responses of a 
similar magnitude have been observed in both COS-7 [24] 
and PC12 cells [25]. With regard to the 42 kDa isoform, 
the time course of dbt-cAMP action appeared to be bipha- 
sic. In addition to changes in cytosolic activity, other 
possible explanations include rapid translocation to the 
nucleus [45] or plasma membrane [46]. Under the condi- 
tions employed in this study, rapamycin has previously 
been shown to completely inhibit the activation of p70 s6k 
by insulin-like growth factor-1 in L6 cells, whilst having 
no effect on other kinases such as p90 rsk or MAP kinase 
[47]. The demonstration i  this work that rapamycin had 
no effect on the ability of cAMP to stimulate translation 
implies that p70 s6k is not involved in eliciting this re- 
sponse in L6 myoblasts. Rather, the data suggest that 
cAMP might, at least in part, phosphorylate $6 via MAP 
kinase activation of p90 rsk. This contrasts with a study in 
CCL39 hamster fibroblasts where elevation of cAMP acti- 
vated p70 s6k [20]. In addition to the possible involvement 
in $6 phosphorylation, cAMP activation of MAP kinase 
may play a role in the stimulation of translation through 
other routes. These include the activation of initiation 
factors such as elF-4E and elF-2B [48]. 
In addition to a role in translational control, our data 
also suggest hat cAMP plays a part in the regulation of 
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transcription. This has previously been shown to be medi- 
ated by the cAMP-responsive element (CRE)-binding pro- 
teins (CREB/ATF) family [49,50]. These factors are phos- 
phorylated by PKA leading to stimulation of the transacti- 
vating potential [51,52]. However, the observation that 
MAP kinase translocates from the cytoplasm to the nu- 
cleus upon activation and the suggestion that the ability of 
this enzyme to phosphorylate ATF-2 regulates binding to 
the CRE [23] implies that MAP kinase may also be 
involved in this response. This awaits further investigation. 
Although cAMP stimulated MAP kinase in L6 cells, it 
had no effect on the stimulation of MAP kinase induced by 
TPA or vasopressin. This suggests that the additive ffects 
on protein synthesis were not mediated at the level of 
MAP kinase activation. This is in contrast to other studies 
where cAMP antagonizes the ability of agents such as 
insulin, TPA, epidermal growth factor and platelet-derived 
growth factor to activate the MAP kinase cascade in rat 
adipocytes [53], fibroblasts [54-57], smooth muscle [58] 
and rat hepatoma cells [59]. In some of these cell types, 
this corresponds with an inhibition of the biological re- 
sponse [53,56]. 
Unlike the effects observed with TPA and vasopressin, 
insulin produced an additive effect with dbt-cAMP on 
protein synthesis at 90 min but not at 6 h, yet it elicited a 
synergistic response with regard to MAP kinase activation. 
Thus, the synergistic MAP kinase response may be in- 
volved in the additive effects of insulin and dbt-cAMP on 
protein synthesis at 90 rain. In addition, the data also 
suggests that the long-term responses to cAMP and insulin 
employ a common pathway at some point. One possibility 
involves CRE modulator (CREM). This is a member of the 
CREB family which seems to play an important role in the 
nuclear esponse to physiological nd neuroendocrine stim- 
uli [50,60]. Interestingly, p70 s6k has recently been shown 
to phosphorylate and activate CREM at the same site in 
vitro as PKA [61]. This suggests a point of convergence 
for the cAMP and insulin pathways as we have previously 
provided evidence implying that insulin stimulates p70 s6k 
in L6 cells [30]. 
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